Reza Avaz, PhD – AI-Enabled Quantification of Cardiovascular Remodeling in Pulmonary Hypertension Jan 30 Reza Avaz, PhD – AI-Enabled Quantification of Cardiovascular Remodeling in Pulmonary Hypertension 3:00 pm - 4:00 pm
Yang Zhou, PhD – Immune Responses in Hermansky-Pudlak Syndrome-associated Lung Disease Feb 6 Yang Zhou, PhD – Immune Responses in Hermansky-Pudlak Syndrome-associated Lung Disease 3:00 pm - 4:00 pm
Arvin Soepriatna, PhD and Stephanie Roser, PhD Feb 13 Arvin Soepriatna, PhD and Stephanie Roser, PhD 3:00 pm - 4:00 pm
Navneet Singh, MD, ScM – The Liver is an Inflammatory Mediator of Pulmonary Arterial Hypertension Feb 20 Navneet Singh, MD, ScM – The Liver is an Inflammatory Mediator of Pulmonary Arterial Hypertension 3:00 pm - 4:00 pm
Daniel Yang, MD – High-throughput functional profiling of MYH7 variants in genome-edited cardiomyocytes to predict cardiomyopathy risk Feb 27 Daniel Yang, MD – High-throughput functional profiling of MYH7 variants in genome-edited cardiomyocytes to predict cardiomyopathy risk 3:00 pm - 4:00 pm
Julia Woodcock, PhD – Exploring Chemical RNA Dynamics in Pulmonary Vascular Diseases Mar 6 Julia Woodcock, PhD – Exploring Chemical RNA Dynamics in Pulmonary Vascular Diseases 3:00 pm - 4:00 pm
Sean Lawler, PhD – Understanding the Role of Cytomegalovirus is Glioblastoma Mar 13 Sean Lawler, PhD – Understanding the Role of Cytomegalovirus is Glioblastoma 3:00 pm - 4:00 pm